Surprise Castle
/Books/Science
The Microbiome in Cancer and Autoimmunity - Part a: Volume 394

The Microbiome in Cancer and Autoimmunity - Part a: Volume 394 - Hardcover

$262.99
Quantity
01

Pay over time for orders over $35.00 with

Availability:In StockContributor:Manisha Singh (Volume Editor)Series:International Review of Cell and Molecular Biology #394Publish date:7/30/2025Pages:226
Language:EnglishPublisher:Academic PressISBN-13:9780443317064ISBN-10:443317062UPC:9780443317064Book Category:ScienceBook Subcategory:Life SciencesBook Topic:Developmental Biology, Molecular BiologySize:8.90 x 6.40 x 0.80 inchesWeight:1.2522Product ID:SC7DGC1GMZ
Microbiome in Cancer and Autoimmunity - Part A, Volume 394 offers a comprehensive exploration of the intricate relationship between the human microbiome and the development of cancer and autoimmune diseases. Delving into cutting-edge research and clinical insights, this groundbreaking work elucidates the role of microbial communities in influencing immune responses, disease pathways, and therapeutic outcomes. From deciphering the molecular mechanisms underlying microbiome-host interactions to unraveling the impact of dysbiosis on disease progression, the book provides a multifaceted analysis of the microbiome's pivotal role in cancer and autoimmunity.

With contributions from leading experts in the field, this book serves as a pivotal resource for researchers, clinicians, and healthcare professionals seeking to understand and harness the therapeutic potential of the microbiome in combating cancer and autoimmune conditions.
Language:EnglishPublisher:Academic PressISBN-13:9780443317064ISBN-10:443317062UPC:9780443317064Book Category:ScienceBook Subcategory:Life SciencesBook Topic:Developmental Biology, Molecular BiologySize:8.90 x 6.40 x 0.80 inchesWeight:1.2522Product ID:SC7DGC1GMZ
Singh, Manisha: - Manisha Singh, PhD, is a trained human and mouse immunologist and during the last 10 years, she has specialized in cancer immunology. The main focus of her work has been to increase the efficacy and understand the molecular mechanisms of various cancer immunotherapies. She is serving as the principal investigator on a 2-year grant ($545,486), having been funded by the US Department of Defense. Dr. Singh's current research is focused on understanding the role of inflammation in immune suppression and resistance to immunotherapy in cancer. Recently, she has submitted the NIH-R01 grant in which she proposed to study the role of IL-1α in immunotherapy induced resistance. She has published 24 peer-reviewed articles and many abstracts in prestigious journals such as Nature Communication, Journal of Immunology, and Journal of Clinical Investigator. Her work has been cited by several prestigious, peer-reviewed, international journals.
Publisher: Academic Press

Contributor(s)

Manisha Singh (Volume Editor)

Free shipping on orders over $75. Standard shipping takes 3-7 business days. Returns accepted within 30 days of purchase.

Recently Viewed

View All